DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Norvasc (Amlodipine) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (22)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Norvasc (Amlodipine) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Norvasc side effects in 76 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 76 year old female, weighing 48.0 kg (105.6 pounds)

Reactions: Malaise, Dyspnoea, Atrioventricular Block Complete

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvasc

Other drugs received by patient: Valsartan and Hydrochlorothiazide; Januvia; Glimicron



Possible Norvasc side effects in 76 year old female

Reported by a physician from Japan on 2012-08-08

Patient: 76 year old female, weighing 48.0 kg (105.6 pounds)

Reactions: Dyspnoea, Malaise, Atrioventricular Block Complete

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvasc

Other drugs received by patient: Januvia; Glimicron; Valsartan and Hydrochlorothiazide



Possible Norvasc side effects in 62 year old male

Reported by a physician from Germany on 2012-07-03

Patient: 62 year old male

Reactions: Pruritus, Toxic Epidermal Necrolysis, Pyrexia, Nikolsky's Sign, Stevens-Johnson Syndrome, Blister

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetylcysteine
    Dosage: 300 mg, 2x/day
    Administration route: Oral
    Indication: Mucous Membrane Disorder
    Start date: 2005-06-29
    End date: 2005-07-12

ALT-Insulin
    Dosage: df
    Indication: Blood Glucose
    Start date: 2005-07-03
    End date: 2005-07-03

Ambroxol
    Dosage: 14 gtt, 2x/day
    Administration route: Oral
    Indication: Mucous Membrane Disorder
    Start date: 2005-07-01
    End date: 2005-07-18

Avelox
    Indication: Chronic Obstructive Pulmonary Disease

Avelox
    Dosage: 400 mg, 1x/day
    Administration route: Oral
    Indication: Infection
    Start date: 2005-06-27
    End date: 2005-07-03

Berotec
    Dosage: 2-3 times weekly
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2004-06-01

Bricanyl
    Dosage: 0.5 df, 2x/day
    Indication: Dyspnoea
    Start date: 2005-06-27
    End date: 2005-07-09

Calcium
    Dosage: 500 mg, 2x/day
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-07-15
    End date: 2005-07-18

Calcium Carbonate
    Dosage: 2 df, 1x/day
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-07-19

Clonidine Hydrochloride
    Dosage: 1.5 g, 1x/day
    Indication: Alcohol Withdrawal Syndrome
    Start date: 2005-06-28
    End date: 2005-06-30

Clonidine Hydrochloride
    Dosage: 1.5 g, 1x/day
    Start date: 2005-07-03
    End date: 2005-07-04

Clorazepate Dipotassium
    Dosage: 5 mg, 3x/day
    Administration route: Oral
    Start date: 2005-07-05
    End date: 2005-07-05

Clorazepate Dipotassium
    Dosage: 5 mg, 3x/day
    Administration route: Oral
    Indication: Sedation
    Start date: 2005-06-27
    End date: 2005-07-02

Delix Plus
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Myocardial Ischaemia
    Start date: 2005-07-03

Digitoxin TAB
    Dosage: 0.1 mg, 1x/day
    Administration route: Oral
    Indication: Myocardial Ischaemia
    Start date: 2005-07-08

Distraneurin
    Dosage: 2.0 df, 3x/day
    Administration route: Oral
    Indication: Alcohol Withdrawal Syndrome
    Start date: 2005-06-30
    End date: 2005-07-03

Ergocalciferol
    Dosage: 1000 iu, 1x/day
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-07-18
    End date: 2005-07-18

Fluticasone Propionate
    Dosage: unk
    Start date: 2005-07-18

Foradil
    Dosage: 1 df, 2x/day
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-06-29
    End date: 2005-07-18

Furosemide
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    Start date: 2005-07-07

Haloperidol
    Dosage: 10 gtt, 1x/day
    Administration route: Oral
    Start date: 2005-07-03
    End date: 2005-07-03

Haloperidol
    Dosage: 10 gtt, 1x/day
    Administration route: Oral
    Indication: Sedation
    Start date: 2005-06-29
    End date: 2005-06-30

Heparin
    Dosage: 25000 iu, 1x/day
    Indication: Thrombosis
    Start date: 2005-06-27
    End date: 2005-07-09

Isoptin
    Dosage: 80 mg, 2x/day
    Administration route: Oral
    Indication: Arrhythmia
    Start date: 2005-07-09

Isoptin
    Dosage: 80 mg unknown frequency
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2005-07-18

Junik
    Dosage: 1 df, 2x/day
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-06-27
    End date: 2005-07-15

Kalinor-Brausetabletten
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2005-07-04
    End date: 2005-07-14

Marcumar
    Dosage: ^df^
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2005-07-10

Nitroglycerin
    Dosage: 50 mg, 1x/day
    Indication: Essential Hypertension
    Start date: 2005-07-02
    End date: 2005-07-02

Norvasc
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Start date: 2005-07-04
    End date: 2005-07-09

Omeprazole
    Dosage: 20 mg, 1x/day, in the evening
    Administration route: Oral
    Indication: Gastric Disorder
    Start date: 2005-07-19

Oxazepam
    Dosage: ^df^
    Administration route: Oral
    Indication: Sedation
    Start date: 2005-07-08
    End date: 2005-07-08

Pantoprazole
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2005-06-29
    End date: 2005-06-30

Pantoprazole
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    Start date: 2005-07-03
    End date: 2005-07-18

Prednisolone
    Dosage: 15 mg, 1x/day
    Administration route: Oral
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-07-16
    End date: 2005-07-18

Prednisolone
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Start date: 2005-07-21
    End date: 2005-07-21

Prednisone TAB
    Dosage: unknown
    Administration route: Oral
    Start date: 2005-07-19

Prednisone TAB
    Dosage: unknown
    Administration route: Oral
    Start date: 2005-07-07
    End date: 2005-07-15

Prednisone TAB
    Dosage: unknown
    Administration route: Oral
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-06-28
    End date: 2005-07-05

Ramipril
    Dosage: ^df daily^
    Administration route: Oral
    Indication: Myocardial Ischaemia
    Start date: 2005-06-30
    End date: 2005-07-02

Salmeterol Xinafoate
    Dosage: unk
    Start date: 2005-07-18

Salutec
    Dosage: 5/25 daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2005-07-03

Sodium Chloride
    Dosage: 1000 ml/day
    Indication: Hypovolaemia
    Start date: 2005-06-27
    End date: 2005-07-03

Spiriva
    Dosage: 1 df, 1x/day
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2004-06-01

Theophylline
    Dosage: 200 - 600 mg
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-06-27
    End date: 2005-06-30

Theophylline
    Dosage: 200 mg, unk
    Start date: 2005-07-21
    End date: 2005-07-21

Theophylline
    Dosage: 600 mg, 1x/day
    Administration route: Oral

Theophylline
    Dosage: 600 mg, 1x/day
    Administration route: Oral
    Start date: 2005-07-03
    End date: 2005-07-09

Theophylline
    Dosage: 200 mg, unk
    Start date: 2005-07-18
    End date: 2005-07-18

Verapamil
    Dosage: 80 mg - 240 mg daily
    Administration route: Oral
    Indication: Tachyarrhythmia
    Start date: 2005-07-18

Verapamil
    Dosage: 80 mg, 3x/day
    Administration route: Oral



Possible Norvasc side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-29

Patient: 62 year old male

Reactions: Pruritus, Toxic Epidermal Necrolysis, Pyrexia, Nikolsky's Sign, Stevens-Johnson Syndrome, Blister

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetylcysteine
    Dosage: 600 mg, 1x/day
    Administration route: Oral
    Start date: 2005-06-29
    End date: 2005-07-12

Acetylcysteine
    Dosage: 300 mg, 2x/day
    Administration route: Oral
    Indication: Mucous Membrane Disorder
    Start date: 2005-06-29
    End date: 2005-07-12

ALT-Insulin
    Dosage: unk
    Indication: Blood Glucose
    Start date: 2005-07-03
    End date: 2005-07-03

Ambroxol
    Dosage: 14 gtt, 2x/day
    Administration route: Oral
    Indication: Mucous Membrane Disorder
    Start date: 2005-07-01
    End date: 2005-07-18

Ambroxol
    Indication: Evidence Based Treatment

Avelox
    Dosage: 400 mg, 1x/day
    Administration route: Oral
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-06-27
    End date: 2005-07-03

Berotec
    Dosage: 2-3 times, weekly
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2004-06-01

Bricanyl
    Dosage: 1 ampoule
    Indication: Dyspnoea
    Start date: 2005-06-27
    End date: 2005-07-09

Calcium
    Dosage: 500 mg, 2x/day
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-07-15
    End date: 2005-07-18

Calcium Carbonate
    Dosage: 2 df, 1x/day
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-07-19

Clonidine Hydrochloride
    Dosage: 1.5 mg, 1x/day
    Indication: Alcohol Withdrawal Syndrome
    Start date: 2005-06-28
    End date: 2005-06-30

Clonidine Hydrochloride
    Dosage: 1.5 mg, 1x/day
    Start date: 2005-07-03
    End date: 2005-07-04

Clorazepate Dipotassium
    Dosage: 5 mg, 3x/day + 10 mg at night
    Administration route: Oral
    Indication: Sedation
    Start date: 2005-06-27
    End date: 2005-07-02

Clorazepate Dipotassium
    Dosage: 5 mg, 3x/day + 10 mg at night
    Administration route: Oral
    Start date: 2005-07-05
    End date: 2005-07-05

Delix Plus
    Administration route: Oral
    Indication: Cardiac Disorder

Digitoxin TAB
    Dosage: 0.1 mg, 1x/day
    Administration route: Oral
    Indication: Cardiac Disorder
    Start date: 2005-07-08

Distraneurin
    Dosage: 2 df, 3x/day
    Administration route: Oral
    Indication: Alcohol Withdrawal Syndrome
    Start date: 2005-06-30
    End date: 2005-07-03

Ergocalciferol
    Dosage: 100 iu, 1x/day
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-07-18
    End date: 2005-07-18

Fluticasone Propionate / Salmeterol
    Indication: Chronic Obstructive Pulmonary Disease

Foradil
    Dosage: 2 df, 1x/day
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-06-29
    End date: 2005-07-18

Furosemid
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2005-07-07

Haloperidol
    Dosage: 10 gtt, 1x/day
    Administration route: Oral
    Start date: 2005-07-03
    End date: 2005-07-03

Haloperidol
    Dosage: 10 gtt, 1x/day
    Administration route: Oral
    Indication: Sedation
    Start date: 2005-06-29
    End date: 2005-06-30

Heparin
    Dosage: 25000 iu, unk
    Indication: Prophylaxis
    Start date: 2005-06-27
    End date: 2005-07-09

Junik
    Dosage: 2 df, 1x/day
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-06-27
    End date: 2005-07-15

Kalinor-Brausetabletten
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2005-07-04
    End date: 2005-07-14

Marcumar
    Dosage: unk
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2005-07-10

Nitroglycerin
    Dosage: 50 mg, unk
    Indication: Hypertension
    Start date: 2005-07-02
    End date: 2005-07-02

Norvasc
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Indication: Cardiac Disorder
    Start date: 2005-07-04
    End date: 2005-07-09

Omeprazole
    Dosage: 20 mg, 1x/day in the evening
    Administration route: Oral
    Indication: Gastric Disorder
    Start date: 2005-07-19

Oxazepam
    Dosage: unk
    Administration route: Oral
    Indication: Sedation
    Start date: 2005-07-08
    End date: 2005-07-08

Pantoprazole
    Dosage: 40 mg, 1x/day
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2005-07-03
    End date: 2005-07-18

Pantoprazole
    Dosage: unk
    Administration route: Oral
    Start date: 2005-06-29
    End date: 2005-06-30

Prednisolone
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-07-19

Prednisolone
    Dosage: 50 mg, 1x/day
    Administration route: Oral
    Start date: 2005-06-28
    End date: 2005-07-05

Prednisolone
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Start date: 2005-07-21
    End date: 2005-07-21

Prednisolone
    Dosage: 80 mg, 1x/day
    Administration route: Oral
    Start date: 2005-07-07
    End date: 2005-07-15

Prednisolone
    Dosage: 15 mg, 1x/day
    Administration route: Oral
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-07-16
    End date: 2005-07-18

Prednisolone
    Dosage: 15 mg, 1x/day
    Administration route: Oral
    Start date: 2005-07-16
    End date: 2005-07-18

Prednisolone
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Start date: 2005-07-21
    End date: 2005-07-21

Prednisolone
    Dosage: 5 mg, unk
    Administration route: Oral

Ramipril
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2005-06-30
    End date: 2005-07-02

Ringer's
    Dosage: 1000 ml, 1x/day
    Indication: Fluid Replacement
    Start date: 2005-06-27
    End date: 2005-07-03

Ringer's
    Indication: Volume Blood Increased

Salutec
    Dosage: 5/25 daily
    Administration route: Oral
    Indication: Coronary Artery Disease
    Start date: 2005-07-03

Spiriva
    Dosage: 1 df, 1x/day
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2004-06-01

Theophylline
    Dosage: 200 mg - 600 mg
    Start date: 2005-06-27
    End date: 2005-06-30

Theophylline
    Dosage: 600 mg, 1x/day
    Administration route: Oral
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2005-07-03
    End date: 2005-07-09

Theophylline
    Dosage: 600 mg, unk

Theophylline
    Dosage: 200 mg, unk
    Start date: 2005-07-21
    End date: 2005-07-21

Theophylline
    Dosage: 200 mg, unk
    Start date: 2005-07-18
    End date: 2005-07-18

Verapamil HCL
    Dosage: 80 mg, 2x/day
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2005-07-09

Verapamil Hydrochloride
    Dosage: 80 mg-240mg, daily
    Administration route: Oral
    Indication: Tachyarrhythmia
    Start date: 2005-07-18

Verapamil Hydrochloride
    Dosage: 80 mg, 3x/day
    Administration route: Oral



Possible Norvasc side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22

Patient: 58 year old male

Reactions: Arthralgia, Hypotension, Dizziness, Headache, Asthenia, Blood Pressure Diastolic Decreased, Abdominal Pain Upper

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Norvasc
    Dosage: 10 mg;qd
    Indication: Product Used FOR Unknown Indication

Pegasys
    Dosage: 180 mcg;qw
    Indication: Hepatitis C
    Start date: 2012-03-22

Ribasphere
    Dosage: 1000 mg;bid
    Indication: Hepatitis C
    Start date: 2012-03-22

Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Other drugs received by patient: Benazepril Hydrochloride W / Hydrochlorothiaz.



Possible Norvasc side effects in 35 year old female

Reported by a physician from Japan on 2012-05-21

Patient: 35 year old female, weighing 48.0 kg (105.6 pounds)

Reactions: Rhabdomyolysis, Overdose, Hypotension, Suicide Attempt, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvasc
    Dosage: 420 mg, 1x/day
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2009-09-02
    End date: 2009-09-02

Voglibose
    Dosage: 26.1 mg, 1x/day
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2009-09-02
    End date: 2009-09-02

Zolpidem
    Dosage: 500 mg, 1x/day
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2009-09-02
    End date: 2009-09-02



Possible Norvasc side effects in 87 year old female

Reported by a physician from Japan on 2012-03-29

Patient: 87 year old female

Reactions: Vascular Insufficiency, Drug Ineffective, Oedema, Condition Aggravated, LEG Amputation, Hypertension

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Anplag (Sarpogrelate Hydrochloride)
    Dosage: (300 mg), oral
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Norvasc
    Dosage: (7.5 mg), oral
    Administration route: Oral
    Indication: Hypertension

Torsemide
    Dosage: 8 mg (8 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Other drugs received by patient: Alprostadil; Pletal; Dorner (Beraprostsodium)



Possible Norvasc side effects in 66 year old male

Reported by a physician from Spain on 2012-03-28

Patient: 66 year old male

Reactions: Nodal Rhythm, Atrioventricular Block, Drug Interaction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvasc

Other drugs received by patient possibly interacting with the suspect drug:
Verapamil HCL
    Dosage: 240 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-01-01
    End date: 2011-10-15

Other drugs received by patient: Acfol; Certican; Luminaletas; Valsartan



Possible Norvasc side effects in 55 year old female

Reported by a consumer/non-health professional from United States on 2012-03-26

Patient: 55 year old female, weighing 96.0 kg (211.2 pounds)

Reactions: Myocardial Infarction, Abdominal Pain Upper

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Arthrotec
    Indication: Arthritis
    Start date: 2003-01-01

Mevacor
    Administration route: Oral

Norvasc
    Indication: Hypertension
    Start date: 2002-01-01

Other drugs received by patient: Metoprolol; Lantus; Isosorbide; Humalog



Possible Norvasc side effects in 87 year old female

Reported by a physician from Japan on 2012-03-13

Patient: 87 year old female

Reactions: Intermittent Claudication, Pain, Oedema, Hypoaesthesia, LEG Amputation, Gait Disturbance, Feeling Cold

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Anplag (Sarpogrelate Hydrochloride)
    Dosage: (300 m), oral
    Administration route: Oral
    Indication: Peripheral Arterial Occlusive Disease
    Start date: 2010-11-23

Norvasc
    Dosage: (7.5 mg), oral
    Administration route: Oral
    Indication: Hypertension

Torsemide
    Dosage: 8 mg (8 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Oedema
    Start date: 2010-12-06
    End date: 2010-12-24

Other drugs received by patient: Pletal; Dorner (Beraprost Sodium); Paulux (Alprostadil)



Possible Norvasc side effects in 66 year old male

Reported by a physician from Spain on 2012-03-13

Patient: 66 year old male

Reactions: Nodal Rhythm, Drug Interaction, Atrioventricular Block

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvasc

Other drugs received by patient possibly interacting with the suspect drug:
Verapamil HCL
    Dosage: 240 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-01-01
    End date: 2011-10-15

Other drugs received by patient: Acfol; Valsartan; Certican; Luminaletas



Possible Norvasc side effects in 55 year old female

Reported by a consumer/non-health professional from United States on 2012-03-07

Patient: 55 year old female, weighing 96.0 kg (211.2 pounds)

Reactions: Myocardial Infarction, Abdominal Pain Upper

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Arthrotec
    Indication: Arthritis
    Start date: 2003-01-01

Mevacor
    Administration route: Oral

Norvasc
    Indication: Hypertension
    Start date: 2002-01-01

Other drugs received by patient: Metoprolol; Lantus; Humalog; Isosorbide



Possible Norvasc side effects in 75 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-02-22

Patient: 75 year old female, weighing 59.9 kg (131.7 pounds)

Reactions: Ear Pain, Headache, Asthenia, Cough

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Altace
    Dosage: 10 mg, unk

Avelox
    Dosage: 400 mg, unk

Norvasc
    Dosage: 5 mg, unk

Other drugs received by patient: Trazodone Hydrochloride; Activant; Ramipril; Amlodipine; Ramipril; Avelox; Oxazepam



Possible Norvasc side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-25

Patient: female, weighing 96.1 kg (211.5 pounds)

Reactions: Myocardial Infarction

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Arthrotec
    Dosage: unk
    Indication: Arthritis
    Start date: 2003-01-01

Lovastatin
    Dosage: unk

Norvasc
    Dosage: 10 mg, daily
    Indication: Hypertension

Other drugs received by patient: Metoprolol; Humalog; Lantus; Isosorbide



Possible Norvasc side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-20

Patient: female, weighing 96.1 kg (211.5 pounds)

Reactions: Myocardial Infarction

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Arthrotec
    Dosage: unk
    Indication: Arthritis
    Start date: 2003-01-01

Lovastatin
    Dosage: unk

Norvasc
    Dosage: 10 mg, daily
    Indication: Hypertension

Other drugs received by patient: Humalog; Lantus; Isosorbide; Metoprolol



Possible Norvasc side effects in 49 year old female

Reported by a consumer/non-health professional from United States on 2011-12-27

Patient: 49 year old female, weighing 70.8 kg (155.7 pounds)

Reactions: LIP Swelling, Pruritus, Swelling Face, Urticaria, Drug Hypersensitivity, Pain, Headache, Wound Haemorrhage, Burning Sensation, Retinopathy Hypertensive, Anxiety, Impaired Driving Ability, Malaise, Communication Disorder, Blindness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvasc

Other drugs received by patient: Catapres



Possible Norvasc side effects in female

Reported by a individual with unspecified qualification from United States on 2011-12-16

Patient: female

Reactions: Stomatitis, Drug Hypersensitivity, Pain, Vaginal Inflammation, Throat Irritation, Oesophagitis, Hypertension, Feeling Abnormal, Influenza

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Diovan
    Indication: Blood Pressure

Exforge
    Indication: Blood Pressure

Norvasc
    Indication: Blood Pressure



Possible Norvasc side effects in 46 year old male

Reported by a physician from Japan on 2011-10-28

Patient: 46 year old male, weighing 72.5 kg (159.6 pounds)

Reactions: Interstitial Lung Disease

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Mobic
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-23

Norvasc
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-08-09

Sutent
    Dosage: 50 mg, 1x/day
    Administration route: Oral
    Indication: Renal Cancer
    Start date: 2011-07-26
    End date: 2011-08-10



Possible Norvasc side effects in 55 year old female

Reported by a physician from Japan on 2011-10-21

Patient: 55 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: Overdose, Urine Output Decreased, Hypotension, Suicide Attempt, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvasc
    Dosage: 5 mg daily
    Administration route: Oral
    Indication: Hypertension

Norvasc
    Dosage: 140 mg, single
    Administration route: Oral
    Start date: 2009-11-05
    End date: 2009-11-05

Olmesartan Medoxomil
    Dosage: 10 mg daily
    Administration route: Oral
    Indication: Hypertension

Olmesartan Medoxomil
    Dosage: 180 mg, single
    Administration route: Oral
    Start date: 2009-11-05
    End date: 2009-11-05



Possible Norvasc side effects in 55 year old female

Reported by a physician from Japan on 2011-10-19

Patient: 55 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: Overdose, Hypotension, Urine Output Decreased, Suicide Attempt, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvasc
    Dosage: 5 mg daily
    Indication: Hypertension

Norvasc
    Dosage: 140 mg, single
    Administration route: Oral
    Start date: 2009-11-05
    End date: 2009-11-05

Olmesartan Medoxomil
    Dosage: 180 mg, single
    Start date: 2009-11-05
    End date: 2009-11-05

Olmesartan Medoxomil
    Dosage: 10 mg daily
    Indication: Hypertension



Possible Norvasc side effects in 55 year old female

Reported by a physician from Japan on 2011-10-11

Patient: 55 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: Overdose, Urine Output Decreased, Hypotension, Suicide Attempt, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvasc
    Dosage: 140 mg, single
    Administration route: Oral
    Start date: 2009-11-05
    End date: 2009-11-05

Norvasc
    Dosage: 5 mg, unk
    Indication: Hypertension

Olmesartan Medoxomil
    Dosage: 10 mg, unk
    Indication: Hypertension

Olmesartan Medoxomil
    Dosage: 180 mg, single



Possible Norvasc side effects in 46 year old male

Reported by a physician from Japan on 2011-10-11

Patient: 46 year old male, weighing 72.5 kg (159.6 pounds)

Reactions: Interstitial Lung Disease

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Mobic
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-23

Norvasc
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-08-09
    End date: 2011-08-11

Sutent
    Dosage: 50 mg, 1x/day
    Administration route: Oral
    Indication: Renal Cancer
    Start date: 2011-07-26
    End date: 2011-08-10

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017